TransCode Therapeutics Stock (NASDAQ: RNAZ) stock price, news, charts, stock research, profile.
You can purchase shares of TransCode Therapeutics (NASDAQ:RNAZ) through any online brokerage.
Other companies in TransCode Therapeutics’s space includes: Tharimmune (NASDAQ:THAR), Dermata Therapeutics (NASDAQ:DRMA), Entero Therapeutics (NASDAQ:ENTO), Cyclacel Pharmaceuticals (NASDAQ:CYCC) and NuCana (NASDAQ:NCNA).
TransCode Therapeutics has a consensus price target of $20.00.
The stock price for TransCode Therapeutics (NASDAQ: RNAZ) is $3.83 last updated December 20, 2024 at 7:00 PM EST.
There are no upcoming dividends for TransCode Therapeutics.
TransCode Therapeutics’s Q3 earnings are confirmed for Thursday, November 14, 2024.
There is no upcoming split for TransCode Therapeutics.
TransCode Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.